Marieke J H Begemann

9PUBLICATIONS
19CO-AUTHORS
Personality and individual differencesChild and adolescent developmentToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 02, 2026
Negative association between cognitive functioning and antipsychotic D2 receptor occupancy, affinity, and dose after first episode psychosis.

Priscilla P Oomen, Shiral S Gangadin, Lieuwe de Haan

|Dec 19, 2025
Determinants of changes in self-esteem after remission of first-episode psychosis: A study of associated cross-sectional and longitudinal factors.

Marit Hidding, Elise van der Stouwe, Bram-Sieben Rosema

|Nov 23, 2025
The Transdiagnostic Association Between Childhood Trauma and Accelerated Brain Aging in Two Independent Datasets.

Lan Zhou, Hugo Schnack, Edwin van Dellen

|Sep 08, 2025
Dopamine D2/3R availability after discontinuation of antipsychotic treatment: a [11C]raclopride PET study in remitted first-episode psychosis patients.

Franciska de Beer, Erik de Vries, Ben Wijnen

|Aug 21, 2025
The Effects of Antipsychotic Dose Reduction on Movement Disorders and Cardiometabolic Indices in Patients Remitted from a First Episode of Psychosis.

Yinzhao Liu, Iris E Sommer, Marieke J H Begemann

|Aug 25, 2023
Addressing the Evidence to Practice Gap: What to Expect From International Antipsychotic Dose Reduction Studies in the Tapering Anti-Psychotics and Evaluating Recovery Consortium.

Sanne Koops, Kelly Allott, Lieuwe de Haan

Pageof 2

Frequent Collaborators

3 joint publications

Wim Veling

3 joint publications

Shiral S Gangadin

2 joint publications

Ben Wijnen

1 joint publications

Kelly Allott